- Erratum
- Open Access
- Published:
Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
BMC Cancer volume 15, Article number: 173 (2015)
Erratum
After publication of this work [1], we noted that we inadvertently failed to include the complete list of all co-authors. The full list of authors and the corrected Authors Contributions section are reported below. We apologize for any inconvenience this oversight may have caused.
Corrected Authors’ List
Alain Hendlisz1*, Vassilis Golfinopoulos1, Amelie Deleporte1, Marianne Paesmans2, Hazem El Mansy1, Camilo Garcia3, Marc Peeters4, Lieven Annemans5, Caroline Vandeputte1, Marion Maetens1, Marc Van den Eynde6, Raphaël Maréchal10, Ivan Borbath6, Damien Dresse7, Ghislain Houbiers8, Michael Fried9, Ahmad Awada1, Martine Piccart1, Jean-Luc Van Laethem10 and Patrick Flamen3
Corrected Authors' contributions
AH, PM, VG Contribution to protocol writing, Manuscript design, Setting-up the trial, Writing manuscript; HEM, AD, CV, MM, MVDE, RM, Writing manuscript; CG, PF, Contribution to protocol writing, Manuscript design, Setting-up the trial, Writing manuscript, Coordination of PET imaging network; PM, AA, MP, Contribution to protocol writing, Setting-up the trial; JVL, Contribution to protocol writing, Setting-up the trial, Writing manuscript. All authors read and approved the final manuscript.
Reference
Alain H, Vassilis G, Amelie D, Marianne P, Hazem El M, Camilo G, et al. Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer. 2013;13:190.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/1471-2407-13-190.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Hendlisz, A., Golfinopoulos, V., Deleporte, A. et al. Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer 15, 173 (2015). https://doi.org/10.1186/s12885-015-1181-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-015-1181-5